Trial intelligence / Profile preview

Melatonin and Amino Acids for Sarcopenia in Elderly

NCT03784495Completed

Sponsor
ASP Pavia
Start
Jan 2014
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of melatonin in Sarcopenia (4 arms), sponsored by ASP Pavia. Primary endpoints: Change in Total Fat Mass at 30 days, Change in Total Free Fat Mass at 30 days and 1 more. Started Jan 2014; status: completed.

02

Drugs

melatonin
03

Conditions

Sarcopenia

Beyond the preview

Go deeper on NCT03784495.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03784495.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call